Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
Bain Capital, a global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) from Mitsubishi Chemical Group Corporation. The investment values the business at approximately $3.3 billion.
TOKYO -- U.S. private equity firm Bain Capital said Monday that backing down on a proposed tender offer for Japanese systems ...
The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences ...
Global private equity and venture capital transaction value totaled $35.28 billion in January, down slightly compared with ...
Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it ...
Keith Largay joins Bain Capital from JLL, where he spent 14 years and most recently served as co-head of its Chicago office.
Bain Capital kicked off the bidding war for MLC-owner Insignia Financial and has certainly pulled out all the stops to ...
BOSTON & BATESVILLE, Ind.--(BUSINESS WIRE)--Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the ...
Taking a look at a Graham Partners-backed technology company that is pursuing a continuation vehicle funding after running a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback